90 related articles for article (PubMed ID: 38480853)
1. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
Lu R; Yang Q; Liu S; Sun L
Oral Health Prev Dent; 2024 Jan; 22():39-50. PubMed ID: 38223960
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk among T cells, epithelial cells, and fibroblasts identifies a prognostic signature in oral squamous cell carcinoma.
Jiang Z; Zhang Z; You X; Ye L; Lin W; Liu L; Cao Y; Pan J
Oral Dis; 2024 May; 30(4):1956-1969. PubMed ID: 37491735
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of VASP serves as a potential prognostic biomarker and therapeutic target for oral squamous cell carcinoma.
Gopalakrishnan K; Kannan B; Pandi C; Pandi A; Ramasubramanian A; Jayaseelan VP; Arumugam P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May; ():. PubMed ID: 38816308
[TBL] [Abstract][Full Text] [Related]
4. Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.
Lagzian A; Askari M; Haeri MS; Sheikhi N; Banihashemi S; Nabi-Afjadi M; Malekzadegan Y
Med Oncol; 2024 Apr; 41(5):108. PubMed ID: 38592406
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
Qi L; Tang Z
Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
[TBL] [Abstract][Full Text] [Related]
6. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
7. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
10. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
11. scAAGA: Single cell data analysis framework using asymmetric autoencoder with gene attention.
Meng R; Yin S; Sun J; Hu H; Zhao Q
Comput Biol Med; 2023 Oct; 165():107414. PubMed ID: 37660567
[TBL] [Abstract][Full Text] [Related]
12. DCAMCP: A deep learning model based on capsule network and attention mechanism for molecular carcinogenicity prediction.
Chen Z; Zhang L; Sun J; Meng R; Yin S; Zhao Q
J Cell Mol Med; 2023 Oct; 27(20):3117-3126. PubMed ID: 37525507
[TBL] [Abstract][Full Text] [Related]
13. Predicting metabolite-disease associations based on auto-encoder and non-negative matrix factorization.
Gao H; Sun J; Wang Y; Lu Y; Liu L; Zhao Q; Shuai J
Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37466194
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
